Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elizabeth M. Kapeel"'
Autor:
Garrett L. Cornelison, Ileana Pedraza, Kendra Garrison, Elizabeth M. Kapeel, Channing Pletka, Abdul Khan, Jessica Momb, Rebecca Martin, Adam Bartos, Joseph D. Dekker, Jay Zhao, John Majercak, Garrett L. Robinson
Publikováno v:
Cancer Research. 83:P4-08
Engineered Toxin Bodies Specific for TROP2 Positive Cancers Authors: Garrett L. Cornelison, Ileana Pedraza, Kendra Garrison, Elizabeth M. Kapeel, Channing Pletka, Abdul Khan, Jessica Momb, Rebecca Martin, Adam Bartos, Joseph D. Dekker, Jay Zhao, John
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41848d10fe5100e4f2a8781c7f5b4dee
https://doi.org/10.1158/1538-7445.sabcs22-p4-08-18
https://doi.org/10.1158/1538-7445.sabcs22-p4-08-18
Autor:
Garrett L. Cornelison, Adam Bartos, Brigitte Brieschke, Jessica Momb, Ileana Pedraza, Elizabeth M. Kapeel, Rebecca Martin, Channing Pletka, Adrian Gonzalez, Joseph D. Dekker, Jay Zhao, John Majercak, Garrett L. Robinson
Publikováno v:
Cancer Research. 82:326-326
Engineered toxin bodies (ETBs) are comprised of a proprietarily engineered form of Shiga-like Toxin A subunit (SLT-A) genetically fused to antibody-like binding domains. ETBs work through novel mechanisms of action and are capable of forced internali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5f2fe9c76ae838b6b9164c80a0f1ce5
https://doi.org/10.1158/1538-7445.am2022-326
https://doi.org/10.1158/1538-7445.am2022-326
Autor:
Swati Khanna, Elizabeth M. Kapeel, Lauren R. Byrne, Elizabeth Saputra, Steven Rivera, Lindsey Aschenbach, Lilia A. Rabia, Garrett L. Cornelison, Rachael M. Orlandella, Brigitte Brieschke, Michaela Sousares, Jay Zhao, Garrett L. Robinson, Chris Moore, Joseph D. Dekker
Publikováno v:
Cancer Research. 82:3543-3543
Targeting of PD-L1 checkpoint has shown clinical efficacy in multiple solid tumor indications. Currently approved PD-L1 targeted approaches rely on the blocking activity of monoclonal antibodies (mAbs) which sterically inhibit PD-L1 thus preventing P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2dbc19c675d76e5455c7b7a21f5cb7
https://doi.org/10.1158/1538-7445.am2022-3543
https://doi.org/10.1158/1538-7445.am2022-3543
Autor:
Rachael M. Orlandella, Elizabeth M. Kapeel, Brigitte Brieschke, Garrett L. Robinson, Joseph D. Dekker, Chris B. Moore
Publikováno v:
Cancer Research. 82:2579-2579
Engineered Toxin Bodies (ETBs) represent a unique therapeutic strategy for fighting cancer by targeting and selectively destroying cancer cells or cancer-promoting immune cells. Featuring an antibody-based targeting domain fused with the cytotoxic, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d3fff8b659798cf01b12c7413b267c6
https://doi.org/10.1158/1538-7445.am2022-2579
https://doi.org/10.1158/1538-7445.am2022-2579